COVID-19 pandemic
The Netherlands officially suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old due to concerns over reports of severe blood clotting.
Sources: NL Times
Changes
- The Netherlands officially halts the use of the vaccine for those aged under 60 years old due to concern over rare severe blood clotting.
- The Netherlands officially halts the use of the Oxford–AstraZeneca vaccine for those aged under 60 years old due to concern over rare severe blood clotting.
- The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine for those aged under 60 years old in the Philippines following reports of possible link with rare cases of blood clots.
- The Netherlands officially suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old due to concerns over reports of severe blood clotting.
- The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following reports of a possible link with rare cases of blood clots.
- The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following reports of a possible link with cases of blood clots.
- The Netherlands officially suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old due to concerns over reports of severe blood clotting.